Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics.

Jeppsson A, Wikkelsö C, Blennow K, Zetterberg H, Constantinescu R, Remes AM, Herukka SK, Rauramaa T, Nagga K, Leinonen V, Tullberg M.

J Neurol Neurosurg Psychiatry. 2019 Jun 5. pii: jnnp-2019-320826. doi: 10.1136/jnnp-2019-320826. [Epub ahead of print]

2.

Dynamics of extracellular matrix proteins in cerebrospinal fluid and serum and their relation to clinical outcome in human traumatic brain injury.

Minta K, Cullen NC, Nimer FA, Thelin EP, Piehl F, Clarin M, Tullberg M, Jeppsson A, Portelius E, Zetterberg H, Blennow K, Andreasson U.

Clin Chem Lab Med. 2019 Apr 15. pii: /j/cclm.ahead-of-print/cclm-2019-0034/cclm-2019-0034.xml. doi: 10.1515/cclm-2019-0034. [Epub ahead of print]

PMID:
30980710
3.

Absence of Disproportionately Enlarged Subarachnoid Space Hydrocephalus, a Sharp Callosal Angle, or Other Morphologic MRI Markers Should Not Be Used to Exclude Patients with Idiopathic Normal Pressure Hydrocephalus from Shunt Surgery.

Agerskov S, Wallin M, Hellström P, Ziegelitz D, Wikkelsö C, Tullberg M.

AJNR Am J Neuroradiol. 2019 Jan;40(1):74-79. doi: 10.3174/ajnr.A5910. Epub 2018 Dec 6.

PMID:
30523139
4.

The phenotype of idiopathic normal pressure hydrocephalus-a single center study of 429 patients.

Agerskov S, Hellström P, Andrén K, Kollén L, Wikkelsö C, Tullberg M.

J Neurol Sci. 2018 Aug 15;391:54-60. doi: 10.1016/j.jns.2018.05.022. Epub 2018 May 30.

PMID:
30103972
5.

Long-term effects of complications and vascular comorbidity in idiopathic normal pressure hydrocephalus: a quality registry study.

Andrén K, Wikkelsö C, Sundström N, Agerskov S, Israelsson H, Laurell K, Hellström P, Tullberg M.

J Neurol. 2018 Jan;265(1):178-186. doi: 10.1007/s00415-017-8680-z. Epub 2017 Nov 29.

6.

Shunt surgery in idiopathic normal pressure hydrocephalus is cost-effective-a cost utility analysis.

Tullberg M, Persson J, Petersen J, Hellström P, Wikkelsø C, Lundgren-Nilsson Å.

Acta Neurochir (Wien). 2018 Mar;160(3):509-518. doi: 10.1007/s00701-017-3394-7. Epub 2017 Nov 17.

7.

Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate.

Edsbagge M, Andreasson U, Ambarki K, Wikkelsø C, Eklund A, Blennow K, Zetterberg H, Tullberg M.

J Alzheimers Dis. 2017;58(3):821-828. doi: 10.3233/JAD-161257.

PMID:
28505972
8.

Veterinary Student Confidence after Practicing with a New Surgical Training Model for Feline Ovariohysterectomy.

Badman M, Tullberg M, Höglund OV, Hagman R.

J Vet Med Educ. Winter 2016;43(4):427-433. Epub 2016 Aug 3.

PMID:
27487110
9.

Amyloid mis-metabolism in idiopathic normal pressure hydrocephalus.

Jeppsson A, Höltta M, Zetterberg H, Blennow K, Wikkelsø C, Tullberg M.

Fluids Barriers CNS. 2016 Jul 29;13(1):13. doi: 10.1186/s12987-016-0037-y.

10.

The APOE Genotype in Idiopathic Normal Pressure Hydrocephalus.

Yang Y, Tullberg M, Mehlig K, Rosengren A, Torén K, Zetterberg H, Wikkelsö C.

PLoS One. 2016 Jul 21;11(7):e0158985. doi: 10.1371/journal.pone.0158985. eCollection 2016.

11.

Pre-and postoperative cerebral blood flow changes in patients with idiopathic normal pressure hydrocephalus measured by computed tomography (CT)-perfusion.

Ziegelitz D, Arvidsson J, Hellström P, Tullberg M, Wikkelsø C, Starck G.

J Cereb Blood Flow Metab. 2016 Oct;36(10):1755-1766. Epub 2015 Oct 14.

12.

In Patients With Idiopathic Normal Pressure Hydrocephalus Postoperative Cerebral Perfusion Changes Measured by Dynamic Susceptibility Contrast Magnetic Resonance Imaging Correlate With Clinical Improvement.

Ziegelitz D, Arvidsson J, Hellström P, Tullberg M, Wikkelsø C, Starck G.

J Comput Assist Tomogr. 2015 Jul-Aug;39(4):531-40. doi: 10.1097/RCT.0000000000000254.

PMID:
25974719
13.

Cerebral perfusion measured by dynamic susceptibility contrast MRI is reduced in patients with idiopathic normal pressure hydrocephalus.

Ziegelitz D, Starck G, Kristiansen D, Jakobsson M, Hultenmo M, Mikkelsen IK, Hellström P, Tullberg M, Wikkelsø C.

J Magn Reson Imaging. 2014 Jun;39(6):1533-42. doi: 10.1002/jmri.24292. Epub 2013 Sep 4.

PMID:
24006249
14.

Influence of comorbidities in idiopathic normal pressure hydrocephalus - research and clinical care. A report of the ISHCSF task force on comorbidities in INPH.

Malm J, Graff-Radford NR, Ishikawa M, Kristensen B, Leinonen V, Mori E, Owler BK, Tullberg M, Williams MA, Relkin NR.

Fluids Barriers CNS. 2013 Jun 10;10(1):22. doi: 10.1186/2045-8118-10-22.

15.

Shunt surgery in patients with hydrocephalus and white matter changes.

Tisell M, Tullberg M, Hellström P, Edsbagge M, Högfeldt M, Wikkelsö C.

J Neurosurg. 2011 May;114(5):1432-8. doi: 10.3171/2010.11.JNS10967. Epub 2011 Jan 14.

PMID:
21235310
16.

Reduced thalamic N-acetylaspartate in idiopathic normal pressure hydrocephalus: a controlled 1H-magnetic resonance spectroscopy study of frontal deep white matter and the thalamus using absolute quantification.

Lundin F, Tisell A, Dahlqvist Leinhard O, Tullberg M, Wikkelsö C, Lundberg P, Leijon G.

J Neurol Neurosurg Psychiatry. 2011 Jul;82(7):772-8. doi: 10.1136/jnnp.2010.223529. Epub 2011 Jan 8.

PMID:
21217158
17.

Symptoms and signs of temporomandibular disorders in patients with sudden sensorineural hearing loss.

Axelsson R, Tullberg M, Ernberg M, Hedenberg-Magnusson B.

Swed Dent J. 2009;33(3):115-23.

PMID:
19994561
18.

White matter diffusion is higher in Binswanger disease than in idiopathic normal pressure hydrocephalus.

Tullberg M, Ziegelitz D, Ribbelin S, Ekholm S.

Acta Neurol Scand. 2009 Oct;120(4):226-34. doi: 10.1111/j.1600-0404.2009.01165.x. Epub 2009 May 26.

PMID:
19485951
19.

Absolute quantification of cerebral blood flow in neurologically normal volunteers: dynamic-susceptibility contrast MRI-perfusion compared with computed tomography (CT)-perfusion.

Ziegelitz D, Starck G, Mikkelsen IK, Tullberg M, Edsbagge M, Wikkelsö C, Forssell-Aronson E, Holtås S, Knutsson L.

Magn Reson Med. 2009 Jul;62(1):56-65. doi: 10.1002/mrm.21975.

20.

Neuropsychological effects of shunt treatment in idiopathic normal pressure hydrocephalus.

Hellström P, Edsbagge M, Blomsterwall E, Archer T, Tisell M, Tullberg M, Wikkelsø C.

Neurosurgery. 2008 Sep;63(3):527-35; discussion 535-6. doi: 10.1227/01.NEU.0000325258.16934.BB.

PMID:
18812964
21.

Cerebrospinal fluid markers before and after shunting in patients with secondary and idiopathic normal pressure hydrocephalus.

Tullberg M, Blennow K, Månsson JE, Fredman P, Tisell M, Wikkelsö C.

Cerebrospinal Fluid Res. 2008 Apr 25;5:9. doi: 10.1186/1743-8454-5-9.

22.

Brain metabolism in adult chronic hydrocephalus.

Kondziella D, Sonnewald U, Tullberg M, Wikkelso C.

J Neurochem. 2008 Aug;106(4):1515-24. doi: 10.1111/j.1471-4159.2008.05422.x. Epub 2008 Apr 14. Review.

23.

The neuropsychology of patients with clinically diagnosed idiopathic normal pressure hydrocephalus.

Hellström P, Edsbagge M, Archer T, Tisell M, Tullberg M, Wikkelsø C.

Neurosurgery. 2007 Dec;61(6):1219-26; discussion 1227-8.

PMID:
18162901
24.

Persistent regional frontotemporal hypoactivity in violent offenders at follow-up.

Anckarsäter H, Piechnik S, Tullberg M, Ziegelitz D, Sörman M, Bjellvi J, Karlsson E, Fernandez NV, Wikkelso C, Forsman A.

Psychiatry Res. 2007 Oct 15;156(1):87-90. Epub 2007 Aug 8.

PMID:
17689934
25.

Ventricular cerebrospinal fluid neurofilament protein levels decrease in parallel with white matter pathology after shunt surgery in normal pressure hydrocephalus.

Tullberg M, Blennow K, Månsson JE, Fredman P, Tisell M, Wikkelsö C.

Eur J Neurol. 2007 Mar;14(3):248-54.

PMID:
17355543
26.

Synthesis of functionalized, unsymmetrical 1,3,4,6-tetrasubstituted 2,5-diketopiperazines.

Tullberg M, Grøtli M, Luthman K.

J Org Chem. 2007 Jan 5;72(1):195-9.

PMID:
17194099
27.

Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury.

Ost M, Nylén K, Csajbok L, Ohrfelt AO, Tullberg M, Wikkelsö C, Nellgård P, Rosengren L, Blennow K, Nellgård B.

Neurology. 2006 Nov 14;67(9):1600-4.

PMID:
17101890
28.

Microwave-assisted solid-phase synthesis of 2,5-diketopiperazines: solvent and resin dependence.

Tullberg M, Luthman K, Grøtli M.

J Comb Chem. 2006 Nov-Dec;8(6):915-22.

PMID:
17096581
29.

Long-term outcome in 109 adult patients operated on for hydrocephalus.

Tisell M, Hellström P, Ahl-Börjesson G, Barrows G, Blomsterwall E, Tullberg M, Wikkelsö C.

Br J Neurosurg. 2006 Aug;20(4):214-21.

PMID:
16954071
30.
31.

Measures of brain morphology and infarction in the framingham heart study: establishing what is normal.

DeCarli C, Massaro J, Harvey D, Hald J, Tullberg M, Au R, Beiser A, D'Agostino R, Wolf PA.

Neurobiol Aging. 2005 Apr;26(4):491-510.

PMID:
15653178
32.

Impaired wakefulness is associated with reduced anterior cingulate CBF in patients with normal pressure hydrocephalus.

Tullberg M, Hellström P, Piechnik SK, Starmark JE, Wikkelsö C.

Acta Neurol Scand. 2004 Nov;110(5):322-30.

PMID:
15476461
33.

Antitumor efficacy and acute toxicity of the novel dipeptide melphalanyl-p-L-fluorophenylalanine ethyl ester (J1) in vivo.

Gullbo J, Lindhagen E, Bashir-Hassan S, Tullberg M, Ehrsson H, Lewensohn R, Nygren P, De La Torre M, Luthman K, Larsson R.

Invest New Drugs. 2004 Nov;22(4):411-20.

PMID:
15292711
34.

White matter lesions impair frontal lobe function regardless of their location.

Tullberg M, Fletcher E, DeCarli C, Mungas D, Reed BR, Harvey DJ, Weiner MW, Chui HC, Jagust WJ.

Neurology. 2004 Jul 27;63(2):246-53.

35.

Structure-activity relationship for alkylating dipeptide nitrogen mustard derivatives.

Gullbo J, Tullberg M, Våbenø J, Ehrsson H, Lewensohn R, Nygren P, Larsson R, Luthman K.

Oncol Res. 2003;14(3):113-32.

PMID:
14760861
36.

Antitumor activity of the novel melphalan containing tripeptide J3 (L-prolyl-L-melphalanyl-p-L-fluorophenylalanine ethyl ester): comparison with its m-L-sarcolysin analogue P2.

Gullbo J, Wallinder C, Tullberg M, Lövborg H, Ehrsson H, Lewensohn R, Nygren P, Luthman K, Larsson R.

Mol Cancer Ther. 2003 Dec;2(12):1331-9.

37.
38.

Activity of hydrolytic enzymes in tumour cells is a determinant for anti-tumour efficacy of the melphalan containing prodrug J1.

Gullbo J, Wickström M, Tullberg M, Ehrsson H, Lewensohn R, Nygren P, Luthman K, Larsson R.

J Drug Target. 2003 Jul;11(6):355-63.

PMID:
14668056
39.

Effects of low-power laser exposure on masseter muscle pain and microcirculation.

Tullberg M, Alstergren PJ, Ernberg MM.

Pain. 2003 Sep;105(1-2):89-96.

PMID:
14499424
40.

Normal pressure hydrocephalus triggers intrathecal production of TNF-alpha.

Tarkowski E, Tullberg M, Fredman P, Wikkelsö C.

Neurobiol Aging. 2003 Sep;24(5):707-14.

PMID:
12885578
41.

Neurological symptoms and signs in adult aqueductal stenosis.

Tisell M, Tullberg M, Hellström P, Blomsterwall E, Wikkelsø C.

Acta Neurol Scand. 2003 May;107(5):311-7.

PMID:
12713521
42.

Correlation between intrathecal sulfatide and TNF-alpha levels in patients with vascular dementia.

Tarkowski E, Tullberg M, Fredman P, Wikkelsö C.

Dement Geriatr Cogn Disord. 2003;15(4):207-11.

PMID:
12626853
43.

Reduced frontotemporal perfusion in psychopathic personality.

Soderstrom H, Hultin L, Tullberg M, Wikkelso C, Ekholm S, Forsman A.

Psychiatry Res. 2002 Jun 15;114(2):81-94.

PMID:
12036508
44.

White matter changes in normal pressure hydrocephalus and Binswanger disease: specificity, predictive value and correlations to axonal degeneration and demyelination.

Tullberg M, Hultin L, Ekholm S, Månsson JE, Fredman P, Wikkelsø C.

Acta Neurol Scand. 2002 Jun;105(6):417-26.

PMID:
12027829
45.
46.

Normal pressure hydrocephalus: vascular white matter changes on MR images must not exclude patients from shunt surgery.

Tullberg M, Jensen C, Ekholm S, Wikkelsø C.

AJNR Am J Neuroradiol. 2001 Oct;22(9):1665-73.

47.

Both total and phosphorylated tau are increased in Alzheimer's disease.

Sjögren M, Davidsson P, Tullberg M, Minthon L, Wallin A, Wikkelso C, Granérus AK, Vanderstichele H, Vanmechelen E, Blennow K.

J Neurol Neurosurg Psychiatry. 2001 May;70(5):624-30.

48.

Postural disturbance in patients with normal pressure hydrocephalus.

Blomsterwall E, Svantesson U, Carlsson U, Tullberg M, Wikkelsö C.

Acta Neurol Scand. 2000 Nov;102(5):284-91.

PMID:
11083504
49.

CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy.

Tullberg M, Månsson JE, Fredman P, Lekman A, Blennow K, Ekman R, Rosengren LE, Tisell M, Wikkelsø C.

J Neurol Neurosurg Psychiatry. 2000 Jul;69(1):74-81.

50.

Reduced regional cerebral blood flow in non-psychotic violent offenders.

Soderstrom H, Tullberg M, Wikkelsö C, Ekholm S, Forsman A.

Psychiatry Res. 2000 Feb 28;98(1):29-41.

PMID:
10708924

Supplemental Content

Loading ...
Support Center